Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Evonik invests over 150 million CAD in a new GMP drug product manufacturing facility in Vancouver to expand lipid-based drug delivery capabilities.
PRIVATEAug 27, 2026•about 3 hours ago
Amount Raised
$150 Million
Round Type
Venture - Series Unknown
ManufacturingBiotechnologyAgriculture and Farmingchemicals
Description
Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. This facility will enhance Evonik's development and manufacturing capacity for advanced pharmaceutical products. The investment aims to support pharmaceutical and biotech customers in bringing innovative medicines to market. Production is expected to begin at the end of 2029.
Company Information
Company
TAA and derivatives business from Evonik
Location
1-11 Rellinghauser Strasse
About
The TAA and derivatives business from Evonik, now part of Sabo, operates production sites in Marl, Germany and Liaoyang, China. It focuses on the production of raw materials used in the manufacture of HALS, enabling outdoor use of plastic products and catering to various industries including automotive, agriculture, construction, and consumer goods.
Don't miss TAA and derivatives business from Evonik's next move
Get an email the moment TAA and derivatives business from Evonik raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contactsMarkus H., Vice President - Head of Global Commerc…
Predictive Intelligence
Strategic
ML-powered predictions for TAA and derivatives business from Evonik's next move
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
TAA and derivatives business from Evonik raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
